Richmond Pharmacology is excited to join the 2026 ACCP Annual Meeting in North Bethesda, Maryland, USA, on 27–29 September 2026.

The meeting theme is “Harnessing Changing Clinical Pharmacology Paradigms to Improve Patient Outcomes”, bringing together clinical pharmacologists, researchers, regulators, and industry leaders to discuss the future of therapeutic development, translational science, and precision medicine.

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer

Our Focus at the Meeting

  • Evolving clinical pharmacology models and emerging therapeutic paradigms
  • Strategies to optimise patient outcomes through precision dosing and PK/PD innovation
  • Regulatory updates affecting drug development and clinical trial design
  • Early‑phase research innovations and translational approaches
  • Collaboration between academia, industry, and global regulatory agencies

Connect With Us

If you are attending the 2026 ACCP Annual Meeting and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: 2026 Annual Meeting Program

Latest news

Leadership Spotlight- Head of Acute Clinical Management

February 20, 2026
In this edition, we spotlight Carolina Pacheco de Amorim, who leads Acute Clinical Management (ACM)
Read more

Events

Clinical Trials Innovation Programme

10 - 11 February 2026
Richmond Pharmacology is pleased to attend the Clinical Trials Innovation Programme Conference in Nice, France, 10–11 February 2026.
View event